Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Sonnet Biotherapeutics Holdings Inc. (SONN)

2.72   0 (0%) 08-14 16:00
Open: 2.7 Pre. Close: 2.72
High: 2.72 Low: 2.56
Volume: 711,759 Market Cap: 31M
SONNET BioTherapeutics, Inc. is a biotechnology company that engages in development of bi and tri functional therapies that can simulate or block immune-modulating targets to control cancer. The company uses albumin binding single chain antibody fragment (scFv) for delivery of recombinant human-cytokines (rH-cytokines) and other validated targets. SONNET BioTherapeutics, Inc. was incorporated in 2015 and is based in Princeton, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.728 - 2.743 2.743 - 2.755
Low: 2.515 - 2.536 2.536 - 2.552
Close: 2.688 - 2.72 2.72 - 2.747

Technical analysis

as of: 2020-08-14 4:34:29 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 6.82     One year: 9.22
Support: Support1: 2.52    Support2: 2.10
Resistance: Resistance1: 5.84    Resistance2: 7.89
Pivot: 3.08
Moving Average: MA(5): 2.78     MA(20): 3.09
MA(100): 4.66     MA(250): 11.90
MACD: MACD(12,26): -0.19     Signal(9): -0.15
Stochastic oscillator: %K(14,3): 3.23     %D(3): 4.16
RSI: RSI(14): 40.04
52-week: High: 54.60  Low: 2.52  Change(%): -82.8
Average Vol(K): 3-Month: 294319  10-Days: 193760

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SONN has closed above bottom band by 28.8%. Bollinger Bands are 60% narrower than normal. The narrow width of the bands suggests low volatility as compared to SONN's normal range. The bands have been in this narrow range for 80 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 14 Aug 2020
Sonnet BioTherapeutics Provides Fiscal Year Third Quarter Business and Earnings Update - BioSpace

Thu, 13 Aug 2020
Sonnet BioTherapeutics Holdings Inc. (SONN) poses a Brand-New Opportunity for Investors with beta value of 1.05 - News Daemon

Wed, 12 Aug 2020
Is Sonnet BioTherapeutics Holdings, Inc. (SONN) a Keeper? Bullish Price Target $7.00 - The News Heater

Tue, 11 Aug 2020
Here is a bargain stock you should look at : Sonnet BioTherapeutics Holdings, Inc. (SONN) - Marketing Sentinel

Tue, 04 Aug 2020
Sonnet BioTherapeutics Announces At-The-Market Warrant Repricing and Exchange Resulting in Expected Gross Proceeds to the Company of up to $10.5 Million - Yahoo Finance

Mon, 03 Aug 2020
Here is why Sonnet BioTherapeutics Holdings Inc. (SONN) stock volatility recorded over the last month was 14.17% - The InvestChronicle

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 9
Shares Float (M) 1
% Held by Insiders 0.77
% Held by Institutions 0.52
Shares Short (K) 556
Shares Short P. Month (K) 516

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -5
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -4.69

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.